Three more cancer drugs are in short supply, according to the FDA and the American Society of Health-System Pharmacists.
Uncategorized
Here are stories covering recent research, treatment, strategy and moves from some of the nation's top cancer hospitals:
New York and California topped all 50 states in appearances on the U.S. News & World Report "2023-24 Best Hospitals for Cardiology, Heart & Vascular Surgery" ranking.
Ten hospitals or health systems with notable heart programs have made Forbes' 2023 list of best places for women to work in the U.S.
Idaho has the top mean pay for cardiologists in the country, according to data from the Bureau of Labor Statistics.
Advertisement
Here are eight legal battles involving cardiologists and heart centers since the start of 2023:
While still in contract negotiations, registered nurses at Dana-Farber Cancer Institute - Merrimack Valley in Methuen, Mass., voted 33 to 1 to authorize a one-day strike, the Massachusetts Nurses Association said in an NBC Boston report.
Researchers at Los Angeles-based City of Hope recently announced promising results for a new chemotherapy pill that "appears to annihilate all solid tumors," according to research published Aug. 1 in Cell Chemical Biology.
The FDA approved GSK's Jemperli (dostarlimab) in combination with carboplatin and paclitaxel for adults with primary advanced or recurrent endometrial cancer who are mismatch repair deficient or microsatellite instability-high.
Daniel Courtade, MD, a cardiologist at UnityPoint Health-St. Luke Hospital in Sioux City, Iowa, and Saint Claire Healthcare in Morehead, Ky., died unexpectedly July 27, according to Cincinnati.com. He was 68.